European Biotech Acquisition Corp. | Business Finance | Business Contracts

Loan Agreement dated February 15, 2023, between European Biotech Acquisition Corp. and Oculis SA (Filed With SEC on February 21, 2023)

Promissory Note dated February 13, 2023, issued by European Biotech Acquisition Corp. to MRMJ Holding B.V (Filed With SEC on February 14, 2023)

Additional Convertible Loan Agreement, dated January 26, 2023 by and among Oculis SA and certain shareholders party thereto (Filed With SEC on January 30, 2023)

Form of Subsequent PIPE Subscription Agreement by and among EBAC and certain investors party thereto (Filed With SEC on January 30, 2023)

Form of PIPE Subscription Agreement by and among EBAC and certain investors party thereto (Filed With SEC on October 17, 2022)

Convertible Loan Agreement, dated October 17, 2022 by and among Oculis SA and certain shareholders party thereto (Filed With SEC on October 17, 2022)

Form of Shareholder Non-Redemption Agreement, by and among Sponsor and certain investors party thereto (Filed With SEC on October 17, 2022)

Oculis Shareholder Support Agreement, dated October 17, 2022 by and among Oculis, EBAC and the other parties thereto (Filed With SEC on October 17, 2022)

Form of Amended and Restated Registration Rights and Lock-Up Agreement by and among New Parent and the other signatories to be a party thereto (Filed With SEC on October 17, 2022)

Private Placement Warrants Purchase Agreement, dated March 15, 2021, between the Company and the Sponsor (Filed With SEC on March 18, 2021)

Registration Rights and Shareholder Agreement, dated March 15, 2021, between the Company and certain security holders (Filed With SEC on March 18, 2021)

Investment Management Trust Agreement, dated March 15, 2021, between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on March 18, 2021)

Warrant Agreement, dated March 15, 2021, between the Company and Continental Stock Transfer & Trust Company, as warrant agent (Filed With SEC on March 18, 2021)

Underwriting Agreement, dated March 15, 2021, between the Company and Credit Suisse Securities (USA) LLC, as representative of the several underwriters (Filed With SEC on March 18, 2021)

Form of Underwriting Agreement (Filed With SEC on March 4, 2021)

Specimen Class A Ordinary Share Certificate (Filed With SEC on March 4, 2021)

Specimen Warrant Certificate (Filed With SEC on March 4, 2021)

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on March 4, 2021)

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on March 4, 2021)

Form of Registration and Shareholder Rights Agreement among the Registrant, the Sponsor and the Holders signatory thereto (Filed With SEC on March 4, 2021)

Form of Private Placement Units Purchase Agreement between the Registrant and the Sponsor (Filed With SEC on March 4, 2021)

Promissory Note, dated as of January 18, 2021, between the Registrant and the Sponsor (Filed With SEC on March 4, 2021)

Securities Subscription Agreement, dated January 18, 2021, between the Registrant and the Sponsor (Filed With SEC on March 4, 2021)

European Biotech Acquisition Corp. (40) | Business Finance (23)